On the public citation graph
https://doi.org/10.2139/ssrn.4679553
0 signed · 19 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.otc.2010.04.003openalex-extracted
A Comprehensive Review of the Adverse Effects of Systemic Corticosteroids
inferredcites →https://doi.org/10.1021/jm049486aopenalex-extracted
Discovery of N -(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays
inferredcites →https://doi.org/10.1021/jm060727jopenalex-extracted
2-Aminothiazole as a Novel Kinase Inhibitor Template. Structure−Activity Relationship Studies toward the Discovery of N -(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (Dasatinib, BMS-354825) as a Potent pan -Src…
inferredcites →https://doi.org/10.1021/jm701095mopenalex-extracted
Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity
inferredcites →https://doi.org/10.1021/jm7010996openalex-extracted
Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation
inferredcites →https://doi.org/10.1038/357161a0openalex-extracted
Profound block in thymocyte development in mice lacking p56lck
inferredcites →https://doi.org/10.1038/nrd.2016.266openalex-extracted
Non-kinase targets of protein kinase inhibitors
inferredcites →https://doi.org/10.1039/c2ob27003jopenalex-extracted
The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib
inferredcites →https://doi.org/10.1080/00397911.2017.1337150openalex-extracted
A convenient new and efficient commercial synthetic route for dasatinib (Sprycel®)
inferredcites →https://doi.org/10.1080/14756366.2021.1937143openalex-extracted
New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights
inferredcites →https://doi.org/10.1124/jpet.105.089169openalex-extracted
A-770041, a Novel and Selective Small-Molecule Inhibitor of Lck, Prevents Heart Allograft Rejection
inferredcites →https://doi.org/10.1126/science.aan4368openalex-extracted
The target landscape of clinical kinase drugs
inferredcites →https://doi.org/10.1146/annurev.cellbio.13.1.513openalex-extracted
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
inferredcites →https://doi.org/10.1158/0008-5472.can-05-4187openalex-extracted
The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants
inferredcites →https://doi.org/10.1172/jci3205openalex-extracted
Defective expression of p56lck in an infant with severe combined immunodeficiency.
inferredcites →https://doi.org/10.1186/1479-5876-6-53openalex-extracted
Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
inferredcites →https://doi.org/10.14233/ajchem.2018.21287openalex-extracted
Scalable and Impurity-Free Process for Dasatinib: Src and BCR-Abl Inhibitor
inferredcites →https://doi.org/10.1517/13543776.2010.517749openalex-extracted
Update on lymphocyte specific kinase inhibitors: a patent survey
inferredcites →https://doi.org/10.2174/138955708784534454openalex-extracted
Small Molecule Inhibitors of Lck: The Search for Specificity within a Kinase Family
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.